
Vice Dean III of the FF UNAIR, apt. Elida Zairina, S.Si., MPH., PhD., FISQua., was entrusted to serve as one of the symposium speakers at The 25th Asian Conference on Clinical Pharmacy (ACCP) 2026, a prestigious scientific conference held in Bangkok, Thailand, on July 9-11, 2026. This year’s conference carried the theme “Borderless Pharmacy Practice: Collaboration for Sustainability and Cultural Integration,” which brought together academics, researchers, healthcare professionals, and clinical pharmacy practitioners from various countries in Asia and around the world.
The trust given to Dr. Elida served as evidence of international recognition of the competence of FF UNAIR lectures and researchers in the field of clinical pharmacy. On the third day of the conference, Saturday (July 11, 2026), she appeared as a speaker presenting material titled “High Risk Medication in the Elderly: How to Optimize Use and Minimize Harm.”
In her presentation, Dr. Elida discussed the importance of optimizing the use of high-risk medications in the elderly population. Geriatric patients have different physiological characteristics and are therefore more susceptible to adverse drug events, drug interactions, and inappropriate medication use. Consequently, evidence-based strategies are needed to ensure therapy that is safe, effective, and oriented toward patient safety.
Dr. Elida’s participation as a speaker at this international forum simultaneously strengthened FF UNAIR’s contribution to the development of clinical pharmacy science at the global level. The presence of FF UNAIR lecturers at the ACCP 2026 served not only as a platform for sharing knowledge and experience but also opened opportunities for research collaboration and academic networks with experts from various countries.
This participation reflects FF UNAIR’s commitment to supporting the internationalization of higher education and producing tangible contributions to the development of more safe, quality, and patient-centered pharmaceutical services. Additionally, this activity aligns with the achievement of SDGs 3 (Good Health and Well-being) through improving patient safety and healthcare service quality, as well as SDGs 17 (Partnerships for the Goals) through strengthening academic and professional collaboration at the international level.
